Drug Type ASO |
Synonyms ARRx, ISIS ARRX, ISIS-ARRx + [9] |
Target |
Action inhibitors |
Mechanism AR-v7 inhibitors(androgen receptor splice variant 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic castration-resistant prostate cancer | Phase 2 | China | 24 Mar 2021 | |
Metastatic castration-resistant prostate cancer | Phase 2 | China | 24 Mar 2021 | |
Metastatic castration-resistant prostate cancer | Phase 2 | China | 24 Mar 2021 | |
Prostatic Cancer | Phase 2 | United Kingdom | 18 Sep 2016 | |
Advanced Malignant Solid Neoplasm | Phase 1 | United States | 01 May 2014 | |
Advanced Malignant Solid Neoplasm | Phase 1 | United Kingdom | 01 May 2014 |